αααααβααΎαBNTC β’ NASDAQ
add
Benitec Biopharma Inc
15.05$
2 α§αααΆ, 8:30:00 PM ααααβααα -4 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·α
αα·αααΈαα»α
14.41$
α
αααααααααααα
14.42$ - 15.69$
α
ααααααα½αααααΆαα
α»αααααα
5.74$ - 16.90$
ααΎαβαα»αβααΈααααΆα
384.47Β ααΆα USD
ααα ααα½αααΌαααααα
54.39Β ααΆαα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
ααααααΆαααΈααααΆα
Yahoo Finance
9 ααααβαα»α
Buffett: This year's stock market turmoil 'is really nothing'
1.81%
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | β | β |
α
αααΆαααααα·ααααα·ααΆα | 8.61Β ααΆα | 24.31% |
α
αααΌααα»ααα | -7.36Β ααΆα | -8.22% |
ααααΆααα
αααααα»ααα | β | β |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | -8.60Β ααΆα | -24.40% |
α’ααααΆαααααααααΆαααααα·αααααΆα | β | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 78.28Β ααΆα | 284.23% |
ααααααααα»α | 79.07Β ααΆα | 270.29% |
ααΆαααα½ααα»αααααΌαααα»α | 3.13Β ααΆα | -46.85% |
ααΌαβααααα»α | 75.94Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 23.45Β ααΆα | β |
ααααααααααΉαααααα
| 4.45 | β |
ααα
ααααααΎαααααα | -29.12% | β |
ααα
ααααααΎααΎααα»α | -30.65% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | -7.36Β ααΆα | -8.22% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | -7.70Β ααΆα | -43.58% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -12.00Β ααΆαα | β |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 17.87Β ααΆα | 45,725.64% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 10.44Β ααΆα | 290.20% |
ααα αΌαααΆα
αααααΆααααααα | -5.70Β ααΆα | -101.38% |
α’αααΈ
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology.
The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research. Wikipedia
ααΆααααααΎαα‘αΎα
1997
αααααβαααααΆα
αα»ααααα·α
16
